| scholarly article | Q13442814 |
| P50 | author | Charles M. Rice | Q22669757 |
| P2093 | author name string | Keril J Blight | |
| John K Rose | |||
| Linda Buonocore | |||
| P2860 | cites work | Binding of hepatitis C virus to CD81 | Q22004178 |
| A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. | Q41689368 | ||
| Glycosylation allows cell-surface transport of an anchored secretory protein | Q44533752 | ||
| An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants | Q45735721 | ||
| Hepatitis C: global prevalence | Q73914212 | ||
| A simple method for displaying the hydropathic character of a protein | Q26778481 | ||
| The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum | Q27469349 | ||
| Attenuated vesicular stomatitis viruses as vaccine vectors | Q27469358 | ||
| A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. | Q27469530 | ||
| Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus | Q27469536 | ||
| Cell fusion activity of hepatitis C virus envelope proteins | Q27469594 | ||
| Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA | Q27860484 | ||
| Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 | ||
| Efficient selection for high-expression transfectants with a novel eukaryotic vector | Q27860810 | ||
| Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase | Q27860943 | ||
| The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 | Q29620136 | ||
| Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals. | Q33555920 | ||
| Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge | Q33783986 | ||
| Folding, assembly and subcellular localization of hepatitis C virus glycoproteins | Q33791619 | ||
| Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies | Q33804540 | ||
| Recombinant vesicular stomatitis viruses from DNA. | Q34337129 | ||
| Preferential localization of effector memory cells in nonlymphoid tissue | Q34514330 | ||
| High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. | Q35889961 | ||
| Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. | Q39595495 | ||
| The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. | Q39874034 | ||
| Cell-Mediated Immunity to Vesicular Stomatitis Virus Infections in Mice | Q40123463 | ||
| Characterization of pseudotype VSV possessing HCV envelope proteins | Q40598617 | ||
| Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope | Q40898990 | ||
| The C-terminal region of the hepatitis C virus E1 glycoprotein confers localization within the endoplasmic reticulum | Q40932523 | ||
| Hepatitis C virus and organ transplantation | Q41074811 | ||
| Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection | Q41090869 | ||
| Therapy of hepatitis C: alpha interferon and ribavirin | Q41598827 | ||
| P433 | issue | 14 | |
| P921 | main subject | virology | Q7215 |
| hepatitis C | Q154869 | ||
| Hepatitis C virus | Q708693 | ||
| virus | Q808 | ||
| vesicular stomatitis | Q11549084 | ||
| P304 | page(s) | 6865-6872 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins | |
| P478 | volume | 76 |
| Q37490583 | "Marker of Self" CD47 on lentiviral vectors decreases macrophage-mediated clearance and increases delivery to SIRPA-expressing lung carcinoma tumors |
| Q45722093 | A model for the study of hepatitis C virus entry |
| Q42216061 | A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis |
| Q54988623 | Animal Models to Study Hepatitis C Virus Infection. |
| Q43049376 | Another putative receptor for hepatitis C virus |
| Q40285451 | Assembly of HCV E1 and E2 glycoproteins into coronavirus VLPs. |
| Q30826612 | Baculovirus display: a multifunctional technology for gene delivery and eukaryotic library development |
| Q36363203 | Broadly neutralizing immune responses against hepatitis C virus induced by vectored measles viruses and a recombinant envelope protein booster |
| Q29619745 | CD81 is required for hepatitis C virus glycoprotein-mediated viral infection |
| Q37839350 | Cell entry of enveloped viruses. |
| Q36385222 | Cell entry of hepatitis C virus |
| Q40539381 | Characterization of functional hepatitis C virus envelope glycoproteins. |
| Q40228962 | Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins |
| Q40100844 | Characterization of retrovirus-based reporter viruses pseudotyped with the precursor membrane and envelope glycoproteins of four serotypes of dengue viruses |
| Q37201846 | Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems |
| Q38046287 | Entry and replication of recombinant hepatitis C viruses in cell culture |
| Q27473287 | Evaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine Vehicle |
| Q40344741 | Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1 |
| Q27472940 | Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector |
| Q42227908 | Generation of infectious HCV pseudo typed particles and its utilization for studying the role of CD81 & SRBI receptors in HCV infection. |
| Q37713979 | Heat shock protein 70 enhances mucosal immunity against human norovirus when coexpressed from a vesicular stomatitis virus vector |
| Q36581588 | Hepatitis C virus entry: molecular biology and clinical implications |
| Q24551041 | Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR |
| Q27477687 | Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles |
| Q42996153 | Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity |
| Q27485318 | Identification of a Broadly Cross-Reacting and Neutralizing Human Monoclonal Antibody Directed against the Hepatitis C Virus E2 Protein |
| Q27491029 | In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes |
| Q40396501 | Inducible vesicular stomatitis virus (VSV) L cell line for packaging of recombinant VSV. |
| Q24673768 | Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes |
| Q38886667 | Lassa-vesicular stomatitis chimeric virus safely destroys brain tumors |
| Q35669529 | Mechanisms of hepatitis C virus infection |
| Q40190351 | Multimeric HCV E2 protein obtained from Pichia pastoris cells induces a strong immune response in mice |
| Q27489898 | Mutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entry |
| Q36179699 | Neutralizing antibodies in hepatitis C virus infection |
| Q36921336 | New therapeutic opportunities for hepatitis C based on small RNA. |
| Q35012894 | No false start for novel pseudotyped vectors |
| Q35139219 | Nonsegmented negative-strand viruses as vaccine vectors |
| Q29620681 | Novel insights into hepatitis C virus replication and persistence |
| Q99637171 | Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies |
| Q36933791 | Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle |
| Q37943585 | Recombinant vaccines against the mononegaviruses--what we have learned from animal disease controls |
| Q36594920 | Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector |
| Q34647625 | Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge |
| Q40402498 | Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01. |
| Q27481021 | Replication-Competent Recombinant Vesicular Stomatitis Virus Encoding Hepatitis C Virus Envelope Proteins |
| Q27481034 | Studying Hepatitis C Virus: Making the Best of a Bad Virus |
| Q40181096 | Tandem repeats of lactoferrin-derived anti-hepatitis C virus peptide enhance antiviral activity in cultured human hepatocytes |
| Q57275154 | Technical considerations for the generation of novel pseudotyped viruses |
| Q34979868 | The challenge of developing a vaccine against hepatitis C virus |
| Q37422843 | The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system |
| Q34742846 | Vesicular stomatitis virus as a vector to deliver virus-like particles of human norovirus: a new vaccine candidate against an important noncultivable virus |
| Q38081966 | Virus-like particle-based vaccines against hepatitis C virus infection. |
Search more.